Loading

Opening Panel: Rethinking access and advancement within the advanced therapies industry

02 Sep 2025
Pau Casals
Women in Advanced Therapies
  • How do overlapping identities affect career progress, opportunities and visibility? 

  • What can organisations and individuals do to build more inclusive and representative communities? 

  • How do we move from representation to genuine inclusion? 

Chairperson
Terri Gaskell, CTO - Rinri Therapeutics
Speakers
Avencia Sanchez-Mejias, CEO & Co-founder - Integra Therapeutics
Keren Leshem, CEO & Board Director - ViVac Pharma
Kat Kozyrytska, Founder - Cell Therapy Manufacturability Program
Mayra Battilani, Former EMEA – Commercial Strategy Director Gene Therapy – Rare Diseases - Johnson & Johnson